Clinical Trial Update: Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effectiveness and safety of adding atypical antipsychotic agents to ongoing SSRI therapy in patients with obsessive-compul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Snippet

Sponsor: Osaka City University | Conditions: SSRI-Refractory Obsessive-Compulsive Disorder | Phase 4 | Status: COMPLETED